Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. [electronic resource]
- Transplantation Feb 2012
- 319-24 p. digital
Publication Type: Journal Article
1534-6080
10.1097/TP.0b013e31823f7eea doi
Adolescent Adult Boronic Acids--therapeutic use Bortezomib Child Graft Rejection--prevention & control HLA Antigens--immunology Heart Transplantation--immunology Humans Infant Isoantibodies--blood Proteasome Inhibitors Pyrazines--therapeutic use Retrospective Studies Tissue Donors